RetCurious
Explorer
Summary
Because glucagon-like peptide-1 (GLP-1) medicines produce such a large drop in body weight, there is concern that lean body mass (LBM) and skeletal muscle might be lost. This work presents four pre-clinical studies plus a proof-of-concept clinical trial that speak to that question. In obese mice, we report, GLP-1 medicines mainly lower body fat, with a small yet significant reduction in LBM. Of the lean tissues, the decline in liver mass is greater than the change in muscle mass. Although absolute muscle mass and strength go down, relative muscle mass and strength go up, which yields better running performance. Notably, GLP-1 medicines affect the muscle proteome differently than calorie restriction does, even though atrophy during immobilization is comparable. In patients with obesity, GLP-1 medicines improve body composition without harming strength. Taken together, in middle-aged mice and men, GLP-1 medicines produce a slight drop in absolute muscle values while having a positive effect on body composition and mobility.
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00082-0#
Because glucagon-like peptide-1 (GLP-1) medicines produce such a large drop in body weight, there is concern that lean body mass (LBM) and skeletal muscle might be lost. This work presents four pre-clinical studies plus a proof-of-concept clinical trial that speak to that question. In obese mice, we report, GLP-1 medicines mainly lower body fat, with a small yet significant reduction in LBM. Of the lean tissues, the decline in liver mass is greater than the change in muscle mass. Although absolute muscle mass and strength go down, relative muscle mass and strength go up, which yields better running performance. Notably, GLP-1 medicines affect the muscle proteome differently than calorie restriction does, even though atrophy during immobilization is comparable. In patients with obesity, GLP-1 medicines improve body composition without harming strength. Taken together, in middle-aged mice and men, GLP-1 medicines produce a slight drop in absolute muscle values while having a positive effect on body composition and mobility.
https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00082-0#